Water-Based Tissue Adhesive Nanoparticles for Strong Wet Bonding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Traditional tissue adhesives, such as cyanoacrylates and polyurethane-based adhesives, pose risks of tissue injury due to exothermal reactions, while biologically-derived fibrin glues suffer from weak wet tissue adhesion strength, viral transmission risks, allergic reactions, and complex production processes, and injectable citrate-based bioadhesives have slow curing rates and low cohesive strength.

Innovation Solution

An adhesive composition comprising nanoparticles with opposite charges and varying sizes, forming ionic crosslinks and potentially covalent bonds through functional groups, mimicking the adhesive mechanism of English ivy and blue mussels, to enhance mechanical strength, adhesion, and durability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If traditional tissue adhesives (cyanoacrylates, polyurethane-based) are used, then adhesive strength is achieved, but tissue injury risk increases due to exothermal reactions

Engineering Contradiction:
Improveadhesive strengthVSAvoidtissue injury risk
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The invention changes the chemical parameters of the adhesive system by using cyanoacrylate monomers with modified molecular structures (different chain lengths, functional groups) and controlling polymerization kinetics through catalyst selection and concentration, thereby reducing exothermal reaction intensity while maintaining adhesive strength

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention introduces intermediary substances such as buffers, chelating agents, and protein additives that mediate between the adhesive chemistry and tissue interaction, reducing direct harmful effects on tissue while preserving bonding capability

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If fibrin glue is used, then biocompatibility is improved, but adhesion strength decreases and production complexity increases

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidadhesion strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The invention creates composite adhesive systems combining cyanoacrylate polymers with biocompatible additives such as gelatin, collagen, or plasma proteins, thereby achieving both strong adhesion and high biocompatibility through synergistic material combinations

Inventive Principle:
Principle #40Composite materials

3Strength

If iCMBAs are used, then adhesion strength is improved, but curing rate decreases and cohesive strength reduces

Engineering Contradiction:
Improveadhesion strengthVSAvoidcuring rate
Core Design Contradiction:
StrengthVSSpeed

Solution Approach 1:

The invention optimizes multiple parameters simultaneously: adjusting pH to enhance catechol reactivity, controlling ionic strength to modulate curing kinetics, and selecting specific metal ion catalysts to accelerate crosslinking while maintaining strong adhesion and cohesive strength

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition achieves improved mechanical strength, adhesion, and water resistance, eliminating the drawbacks of chemical reactions and enhancing durability, suitable for tissue closure, drug delivery, and cosmetic applications.

Implementation Method 1

forming ionic crosslinks and potentially covalent bonds through functional groups

Methodology Applied
Scientific EffectIonic crosslinks: Ion Repulsion/Attraction

Implementation Method 2

covalent bonds through functional groups

Methodology Applied
Scientific EffectChemical bonding: Chemical Bonding

Data Source

PatentUS12544481B2Water-based tissue adhesives
Publication Date: 2026.02.10 ALEO BME INC
  • US12544481B2 patent drawing
  • US12544481B2 patent drawing
  • US12544481B2 patent drawing

AI summary

An adhesive composition described herein comprises an aqueous solvent; and a population of first nanoparticles dispersed in the aqueous solvent, the first nanoparticles comprising a negative or positive charge, and an average size in three dimensions of 1 nm to 1000 nm. In some embodiments, a population of second nanoparticles is dispersed in the aqueous solvent, the second nanoparticles comprises a negative or positive charge opposite the charge of the population of first nanoparticles. In some embodiments, the population of first nanoparticles comprise an average first size in three dimensions, and the population of second nanoparticles comprise an average second size in three dimensions that is different from the average first size of the first nanoparticles.